Introductory Chapter: “Feel Good” Chemical Dopamine - Role in Health and Disease
Author:
Yenisetti Sarat Chandra
Reference15 articles.
1. Calabresi P, Picconi B, Tozzi A, Di Fillippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends in Neurosciences. 2007;30(5):211-219
2. Tolleson C, Classen D. The function of tyrosine hydroxylase in the normal and Parkinsonian brain. CNS and Neurological Disorders-Drug Targets. 2012;11(4):381-386
3. Mousseau DD, Baker GB. Recent developments in the regulation of monoamine oxidase form and function: Is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain dysfunction? Current Topics in Medicinal Chemistry. 2012;12(20):2163-2176
4. Maas JW, Bowden CL, Miller AL, et al. Schizophrenia, psychosis, and cerebrospinal fluid homovanillic acid concentrations. Schizophrenia Bulletin. 1997;23(1):147-154
5. DeMaagd G, Phillip A. Parkinson’s disease and its management. Part 5: Treatment of nonmotor complications. Pharmacy and Therapeutics. 2015;40(12):838-842